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Background/aim: The relevance of HIV infection in perioperative renal risk stratification remains unclear. This research sought to
investigate the impact of HIV infection, as well as other established preoperative risk factors for poor perioperative renal outcome
(PPRO), in a population of 565,225 adult noncardiac surgery patients whose data were obtained from the 2009–2011 California State
Inpatient Database.
Materials and methods: HIV status, established preoperative risk factors, and the study outcome (PPRO) were determined with the
Clinical Classification Software codes recorded for each patient. Data were analyzed using univariate (Mann–Whitney U test, chisquare, and Fisher’s exact test) and multivariate (binary logistic regression) statistical methods.
Results: The established preoperative risk factors were independently associated with PPRO. HIV infection was not an independent risk
factor for PPRO in this study (odds ratio: 1.573, 95% confidence interval: 0.998–2.480; P = 0.051). Patients with HIV infection tended to
have a higher burden of certain established preoperative risk factors for PPRO than patients without HIV infection.
Conclusion: HIV-infected patients should be thoroughly screened for established preoperative risk factors and carefully managed
during the perioperative period to reduce their risk of PPRO.
Key words: HIV, noncardiac surgery, renal outcomes

1. Introduction
Renal dysfunction in nonsurgical, hospitalized HIVinfected patients is associated with significant morbidity
and mortality. For instance, Lopes et al. found an almost
70% higher risk of long-term mortality in HIV-infected
patients with acute kidney injury in comparison to HIVinfected patients without acute kidney injury (1). The
prevalence of poor perioperative renal outcome (PPRO)
in the hospitalized HIV-infected population has been
estimated between 1.3% and 2.0% (2,3). It is unclear
whether HIV infection is an independent risk factor for
PPRO following noncardiac surgical procedures. The
purpose of this study was to determine whether HIV
infection is an independent risk factor for PPRO in
patients undergoing noncardiac surgery when established
preoperative risk factors are accounted for. We did not
include cardiac surgery patients in this research for
two reasons. First, renal dysfunction following cardiac
surgery has been extensively studied (4). Second, the
pathophysiology of renal dysfunction in noncardiac
surgery patients is distinct from that observed in cardiac
surgery patients (4) and therefore warrants investigation
through a separate research study.
* Correspondence: moodleyyo@ukzn.ac.za
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2. Materials and methods
This study was a subanalysis of data obtained for 565,225
adult patients (≥18 years old) undergoing various
noncardiac surgery procedures (Table 1). Their data
were obtained from the 2009–2011 California State
Inpatient Database (SID). All data recorded in the SID are
deidentified and publically available. The use of the data
for this study was approved by the Biomedical Research
Ethics Committee of the University of KwaZulu-Natal,
South Africa. Clinical Classification Software (CCS) codes
proposed by the Healthcare Cost and Utilization Project
(Table 2) and the “present on admission” field in the SID
were used to identify diagnoses of HIV infection and
several established preoperative comorbid risk factors for
PPRO (5,6). The CCS codes are predefined groupings of the
International Classification of Disease, 9th edition (ICD9) codes, proposed by the Healthcare Cost and Utilization
Project, and are listed in Table 2. Surgical procedures were
stratified according to procedural risk (Table 1).
Data related to patient age, sex, and emergent hospital
admission were extracted from the SID for this study. The
study outcome, PPRO, was defined as any of the following
diagnoses that were not present on admission to hospital:
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Table 1. Proportion of patients included in the study population stratified by
surgical procedure.
Surgical procedure

n (% of study population)

Above-knee amputation

4184 (0.7)

Below-knee amputation

11,735 (2.1)

Carotid endarterectomy

19,711 (3.5)

Colectomy

32,621 (5.8)

a

2558 (0.5)

Cystectomya
Gastrectomy

13,475 (2.4)

Hip arthroplasty

100,677 (17.8)

Knee arthroplasty

138,895 (24.6)

Laparoscopic cholecystectomy

109,529 (19.4)

Lower extremity peripheral bypass surgery

9344 (1.7)

Nephrectomya

11,448 (2.0)

a

Open abdominal aortic aneurysm repair

3610 (0.6)

Open cholecystectomya

13,632 (2.4)

Pancreatic resection

2682 (0.5)

Spinal fusion

91,124 (16.1)

Total

565,225 (100.0)

a

a

Defined as a high-risk surgical procedure in this study.

a

nephritis/nephrosis/renal sclerosis, acute and unspecified
renal failure, or renal failure. In order to simplify the
process of identifying patients in the SID who suffered
from PPRO, CCS discharge diagnosis codes were used
(Table 2), specifically CCS codes 156 (nephritis/nephrosis/
renal sclerosis), 157 (acute and unspecified renal failure),
and 158 (renal failure). The corresponding ICD-9 codes
for PPRO are shown in Table 2. For the statistical analysis,
age data were not found to be normally distributed and
were subsequently analyzed with an independent Mann–
Whitney U test. Data related to sex, race, admission
route, and comorbidity were dichotomized and analyzed
with Pearson’s chi-square test or Fisher’s exact test as
appropriate. Independent predictors of PPRO were
identified with a binary logistic regression model. P < 0.05
was considered statistically significant. Data were analyzed
with SPSS 22.0 (IBM Corp., Armonk, NY, USA).
3. Results
The characteristics of the study population are presented
in Table 3. Fourteen percent of surgical procedures
were categorized as high-risk surgeries (Table 1).
Approximately 59% of the study population was female.
The median patient age was 64.0 (interquartile range:
52.0–74.0) years. Almost 29% of patients were admitted as
emergent cases. Hypertension (56.0%), diabetes (22.5%),

and peripheral vascular disease (8.1%) were the most
prevalent comorbidities. HIV infection was present in
0.1% of noncardiac surgery patients.
The incidence of PPRO in this study was 2.21% (95%
confidence interval: 2.17–2.25). Crude associations were
observed between all patient clinical characteristics and
PPRO, with the exception of HIV infection (P = 0.344,
Table 3). In this study, all the established preoperative
clinical risk factors for PPRO in the studies of Kheterpal
et al. (5,6) were found to be independent predictors of
PPRO (Table 4). HIV infection was not identified as an
independent predictor of PPRO following noncardiac
surgery (Table 4; odds ratio: 1.573, 95% confidence
interval: 0.998–2.480; P = 0.051).
A subanalysis was performed to identify any potential
differences in the burden of established preoperative risk
factors for PPRO between the HIV-infected and HIVuninfected groups (Z-test for two population proportions;
Table 5). There was a higher prevalence of liver disease,
renal disease, emergent admission, and male sex in the
HIV-infected patient group when compared to the HIVuninfected group. In addition, the HIV-infected patient
group was younger than the HIV-uninfected patient group
(Mann–Whitney U test; Table 5). Diabetes, hypertension,
and congestive heart failure were more common in the HIVuninfected group. Peripheral vascular disease and chronic
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Table 2. CCS and ICD-9 codes used to identify comorbidities and study outcome.
Comorbidity/study outcome

CCS code(s)

ICD-9 code/s

HIV

5

042 0420 0421 0422 0429 0430 0431 0432 0433 0439 0440 0449 07953
27910 27919 79571 7958 V08

49, 50

24900 25000 25001 7902 79021 79022 79029 7915 7916 V4585 V5391
V6546 24901 24910 24911 24920 24921 24930 24931 24940 24941
24950 24951 24960 24961 24970 24971 24980 24981 24990 24991
25002 25003 25010 25011 25012 25013 25020 25021 25022 25023
25030 25031 25032 25033 25040 25041 25042 25043 25050 25051
25052 25053 25060 25061 25062 25063 25070 25071 25072 25073
25080 25081 25082 25083 25090 25091 25092 25093

Hypertension

98, 99

4011 4019 4010 40200 40201 40210 40211 40290 40291 4030 40300
40301 4031 40310 40311 4039 40390 40391 4040 40400 40401 40402
40403 4041 40410 40411 40412 40413 4049 40490 40491 40492 40493
40501 40509 40511 40519 40591 40599 4372

Congestive heart failure

108

39891 4280 4281 42820 42821 42822 42823 42830 42831 42832 42833
42840 42841 42842 42843 4289

Peripheral vascular disease

4400 4401 4402 44020 44021 44022 44023 44029 4404 4408 4409
4439 5570 5571 5579 4410 44100 44101 44102 44103 4411 4412 4413
4414 4415 4416 4417 4419 4420 4421 4422 4423 44281 44282 44283
44284 44289 4429 44321 44322 44323 44324 44329 44770 44771
44772 44773 4440 44401 44409 4441 44421 44422 44481 44489 4449
114, 115, 116, 117
44501 44502 44581 44589 4430 4431 44381 44382 44389 4460 4461
4462 44620 44621 44629 4463 4464 4465 4466 4467 4470 4471 4472
4473 4474 4475 4476 4478 4479 4480 4481 4489 4580 4581 4588 4589
4590 45989 4599 7859 79430 79431 79439 7962 V125 V1250 V1253
V1254 V1259 V151 V421 V432 V4321 V4322 V434 V717

Chronic obstructive pulmonary disease

127

490 4910 4911 4912 49120 49121 49122 4918 4919 4920 4928 494
4940 4941 496

Renal disease

156, 157, 158

5800 5804 58081 58089 5809 5810 5811 5812 5813 58181 58189 5819
5820 5821 5822 5824 58281 58289 5829 5830 5831 5832 5834 5836
5837 58381 58389 5839 587 5845 5846 5847 5848 5849 586 585 5851
5852 5853 5854 5855 5856 5859 7925 V420 V451 V4511 V4512 V560
V561 V562 V5631 V5632 V568

Liver disease

151

570 5715 5716 5718 5719 5720 5721 5722 5723 5724 5728 5730 5734
5735 5738 5739 7824 7891 7895 78959 7904 7905 7948 V427

PPRO (Study outcome)

***

***

Diabetes

***Same as the “renal disease” variable, except diagnosis listed as not present on admission to hospital.

obstructive pulmonary disease were more prevalent in
the HIV-infected patient group when compared to the
HIV-uninfected patient group, although this difference
was not statistically significant (Table 5). Additionally,
median renal risk index scores (6) were calculated for
the HIV-infected (median score: 2.0, interquartile range:
2.0–4.0) and HIV-uninfected groups (median score: 2.0,
interquartile range: 1.0–4.0). There was no statistically
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significant difference in median renal risk index scores
between the two groups (Mann–Whitney U test; Table 5).
4. Discussion
All the established preoperative risk factors for PPRO
in noncardiac surgery patients identified in the studies
of Kheterpal et al. (5,6) were found to be independently
associated with a higher risk of PPRO in this study.
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Table 3. Characteristics of the study population expressed as a frequency (%).
Characteristic

All patients
(n = 565,225)

Patients with PPRO
(n = 12,500)

Patients without PPRO
(n = 552,725)

P-value

Median age in years (interquartile range)

64.0 (52.0-74.0)

73.0 (63.0–82.0)

64.0 (52.0–74.0)

<0.001

Male sex

233,676 (41.3)

7153 (57.2)

226,523 (41.0)

<0.001

Emergent admission

162,979 (28.8)

5662 (45.3)

157,317 (28.5)

<0.001

High-risk procedure

80,026 (14.2)

4831 (38.6)

75,195 (13.6)

<0.001

HIV infection

734 (0.1)

20 (0.2)

714 (0.1)

0.344

Diabetes

127,003 (22.5)

4903 (39.2)

122,100 (22.1)

<0.001

Hypertension

316,348 (56.0)

9581 (76.6)

306,767 (55.5)

<0.001

Congestive heart failure

23,854 (4.2)

2414 (19.3)

21,440 (3.9)

<0.001

Peripheral vascular disease

45,740 (8.1)

2732 (21.9)

43,008 (7.8)

<0.001

Chronic obstructive pulmonary disease

37,502 (6.6)

1863 (14.9)

35,639 (6.4)

<0.001

Renal disease

49,349 (8.7)

4845 (38.8)

44,504 (8.1)

<0.001

Liver disease

20,225 (3.6)

793 (6.3)

19,432 (3.5)

<0.001

Table 4. Characteristics independently associated/not independently associated with PPRO in
noncardiac surgery patients.
Characteristic

Odds ratio
(95% confidence interval)

P-value

Age (per 1 year increase)

1.031 (1.029–1.032)

<0.001

Male sex

1.557 (1.500–1.616)

<0.001

Emergent admission

1.460 (1.405–1.517)

<0.001

High-risk procedure

3.463 (3.332–3.600)

<0.001

HIV infection

1.573 (0.998–2.480)

0.051

Diabetes

1.289 (1.239–1.342)

<0.001

Hypertension

1.311 (1.252–1.373)

<0.001

Congestive heart failure

1.992 (1.890–2.099)

<0.001

Peripheral vascular disease

1.333 (1.271–1.398)

<0.001

Chronic obstructive pulmonary disease

1.279 (1.211–1.350)

<0.001

Renal disease

3.203 (3.068–3.345)

<0.001

Liver disease

1.258 (1.163–1.361)

<0.001

However, HIV infection was not independently
associated with a higher risk of PPRO. There is a potential
explanation for this finding. Although we do not present
data on antiretroviral therapy use, it is likely that as with
the nonsurgical HIV-infected American population (7),
HIV infection was well controlled through management
with antiretroviral therapy in our study population of
surgical patients. In medically treated HIV populations,
antiretroviral therapy is noted to reduce the risk of
patient morbidity and mortality. The positive impact

of antiretroviral therapy on patient outcomes would no
doubt extend to perioperative settings. Indeed, a casecontrol study by King et al. reported a reduction in 30-day
postoperative mortality in HIV-infected patients receiving
antiretroviral therapy versus HIV-infected patients
who did not receive treatment (8). Furthermore, CD4
counts are higher in HIV-infected patients who receive
antiretroviral therapy versus HIV-infected patients who
do not receive treatment. Moreover, King et al. reported
that the mortality risk associated with HIV infection and
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Table 5. Prevalence of established preoperative risk factors for PPRO in HIV-infected and HIV-uninfected patients expressed
as proportions of each population.
Preoperative risk factor

HIV-infected population

HIV-uninfected population

P-value

Median age (interquartile range)

51.0 (46.0–58.0)

64.0 (52.0–74.0)

<0.001

Male sex

0.903

0.413

<0.001

Emergent admission

0.349

0.288

<0.001

High-risk procedure

0.149

0.142

0.589

Diabetes

0.166

0.225

<0.001

Hypertension

0.405

0.560

<0.001

Congestive heart failure

0.025

0.042

0.017

Peripheral vascular disease

0.084

0.081

0.726

Chronic obstructive pulmonary disease

0.066

0.069

0.728

Renal disease

0.135

0.066

<0.001

Liver disease

0.106

0.036

<0.001

Median perioperative renal risk
index score (interquartile range)

2.0 (2.0–4.0)

2.0 (1.0–4.0)

0.076

a CD4 cell count of >200/µL was equivalent to that of an
uninfected patient aged >16 years, whereas the mortality
risk in a patient with a CD4 cell count of >50/µL was
equivalent to that of an uninfected patient aged >47 years
(8). It is therefore possible that adequate management
of HIV infection in our study population resulted in no
overall difference in the levels of risk for PPRO observed
between HIV-infected and HIV-uninfected patients. The
mechanism likely to be responsible for this observation is
the improvement or maintenance of an acceptable CD4
count in patients who received antiretroviral therapy.
A subanalysis found a higher prevalence of several
established risk factors for PPRO in the HIV-infected
patient group when compared with the HIV-uninfected
patient group. However, this did not translate into a higher
risk for PPRO in patients with HIV. When the renal risk
index of Kheterpal et al. was applied to the data, the median
risk scores in HIV-infected and HIV-uninfected patient
groups were not statistically different. Therefore, whereas
the prevalence of certain renal risk factors might be higher
in the HIV-infected population, this is negated by the
higher prevalence of the remaining risk factors in the HIVuninfected group. This highlights potential differences in
the importance of perioperative renal risk factors between
HIV-infected and HIV-uninfected noncardiac surgery
patients and requires further investigation.
There were limitations to this study. The SID did not
contain data that could be used to calculate body mass
index, which is one of the established preoperative risk
factors for PPRO. Therefore, this study was unable to
investigate the impact of this variable on the incidence
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of PPRO. In addition, only in-hospital renal outcomes
are reported for the study population, as postdischarge
outcomes were not recorded in the SID. The SID did not
contain data related to CD4 counts and antiretroviral
therapy use; therefore, it was not possible to investigate
these variables in the subanalysis. Finally, the SID data
represent the US population and cannot be generalized
to other parts of the world, since there may be significant
differences among healthcare systems, treatment
approaches, and patient characteristics. Prospectively
designed research, conducted in several regions around
the world, is required to overcome the limitations reported
in this study.
In conclusion, the findings of this study suggest that
although HIV infection might not be an independent
risk factor for PPRO in the setting of noncardiac surgery,
patients with HIV infection carry many preoperative risk
factors for PPRO. Therefore, HIV-infected patients should
be thoroughly screened for established preoperative risk
factors and carefully managed during the perioperative
period to reduce their risk of PPRO.
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